Histologic mimickers of thick melanoma

Current Diagnostic Pathology

Volumn 9, Issue 5, 2003, Pages 287-295

  Sakkinen, P ^a   Kohler, S ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Melanoma; Pathology; Review

Indexed keywords

ANGIOSARCOMA; BLUE NEVUS; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; FIBROXANTHOMA; HISTIOCYTOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; JUVENILE XANTHOGRANULOMA; LEIOMYOSARCOMA; MELANOCYTIC NEVUS; MELANOMA; NERVE SHEATH TUMOR; PHENOTYPE; SQUAMOUS CELL CARCINOMA;

EID: 0242643556     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-6053(03)00048-6     Document Type: Conference Paper

References (60)

1. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908.
2. National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27-29, 1992. Am J Dermatopathol 1993; 15: 34-43; discussion 46-51.
3. Weedon D, Little J H. Spindle and epithelioid cell naevi in children and adults. A review of 211 cases of the Spitz nevus. Cancer 1977; 40: 217-225.
4. Peters M S, Goellner J R. Spitz naevi and malignant melanomas of childhood and adolescence. Histopathology 1986; 10: 1289-1302.
5. Walsh N, Crotty K, Palmer A, McCarthy S. Spitz nevus versus spitzoid malignant melanoma: an evaluation of the current distinguishing histopathologic criteria. Hum Pathol 1998; 29: 1105-1112.
6. Crotty K A, McCarthy S W, Palmer A A et al. Malignant melanoma in childhood: a clinicopathologic study of 13 cases and comparison with Spitz nevi. World J Surg 1992; 16: 179-185.
7. Bergman R, Malkin L, Sabo E, Kerner H. MIB-I monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi. J Am Acad Dermatol 2001; 44: 500-504.
8. Bastian B C, Wesselmann U, Pinkel D, Leboit P E. Molecular cytogenetic analysis of Spitz naevi shows clear differences to melanoma. J Invest Dermatol 1999; 113: 1065-1069.
9. Bastian B C, LeBoit P E, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000; 157: 967-972.
10. Lohmann C M, Coit D G, Brady M S, Berwick M, Busam K J. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumours. Am J Surg Pathol 2002; 26: 47-55.
11. Rodriguez H A, Ackerman L V. Cellular blue nevus. Clinicopathologic study of forty-five cases. Cancer 1968; 21: 393-405.
12. Sterchi J M, Muss H B, Weidner N. Cellular blue nevus simulating metastatic melanoma: report of an unusually large lesion associated with nevus-cell aggregates in regional lymph nodes. J Surg Oncol 1987; 36: 71-75.
13. Granter S R, McKee P H, Calonie E, Mihm M C, Jr., Busam K. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus'. Am J Surg Pathol 2001; 25: 316-323.
14. Tran T A, Carlson J A, Basaca P C, Mihm M C. Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases. J Cutan Pathol 1998; 25: 252-258.
15. Busam K J. Metastatic melanoma to the skin simulating blue nevus. Am J Surg Pathol 1999; 23: 276-282.
16. Ball N J, Golitz L E. Melanocytic naevi with focal atypical epithelioid cell components: a review of seventy-three cases. J Am Acad Dermatol 1994; 30: 724-729.
17. Seab J A, Jr., Graham J H, Helwig E B. Deep penetrating nevus. Am J Surg Pathol 1989; 13: 39-44.
18. Cooper P H. Deep penetrating (plexiform spindle cell) nevus. A frequent participant in combined nevus. J Cutan Pathol 1992; 19: 172-180.
19. Ducatman B S, Scheithauer B W, Piepgras D G, Reiman H M, Ilstrup D M. Malignant peripheral nerve sheath tumours. A clinicopathologic study of 120 cases. Cancer 1986; 57: 2006-2021.
20. King R, Busam K, Rosai J. Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumour: report of 16 cases. Am J Surg Pathol 1999; 23: 1499-1505.
21. Boyle J L, Haupt H M, Stern J B, Multhaupt H A. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumours. Arch Pathol Lab Med 2002; 126: 816-822.
22. Fletcher C D, Chan J K, McKee P H. Dermal nerve sheath myxoma: a study of three cases. Histopathology 1986; 10: 135-145.
23. Gallager R L, Helwig E B. Neurothekeoma - a benign cutaneous tumour of neural origin. Am J Clin Pathol 1980; 74: 759-764.
24. Barnhill R L, Mihm M C, Jr. Cellular neurothekeoma. A distinctive variant of neurothekeoma mimicking nevomelanocytic tumours. Am J Surg Pathol 1990; 14: 113-120.
25. Calonje E, Wilson-Jones E, Smith N P, Fletcher C D. Cellular 'neurothekeoma': an epithelioid variant of pilar leiomyoma? Morphological and immunohistochemical analysis of a series. Histopathology 1992; 20: 397-404.
26. Zelger B G, Steiner H, Kutzner H, Maier H, Zelger B. Cellular 'neurothekeoma': an epithelioid variant of dermatofibroma? Histopathology 1998; 32: 414-422.
27. Wang A R, May D, Bourne P, Scott G. PGP9.5: a marker for cellular neurothekeoma. Am J Surg Pathol 1999; 23: 1401-1407.
28. Sonoda T, Hashimoto H, Enjoji M. Juvenile xanthogranuloma. Clinicopathologic analysis and immunohistochemical study of 57 patients. Cancer 1985; 56: 2280-2286.
29. Glusac E J, Barr R J, Everett M A, Pitha J, Santa Cruz D J, Epithelioid cell histiocytoma. A report of 10 cases including a new cellular variant. Am J Surg Pathol 1994; 18: 583-590.
30. Glusac E J, McNiff J M. Epithelioid cell histiocytoma: a simulant of vascular and melanocytic neoplasms. Am J Dermatopathol 1999; 21: 1-7.
31. Zelger B, Cerio R, Orchard G, Wilson-Jones E. Juvenile and adult xanthogranuloma. A histological and immunohistochemical comparison. Am J Surg Pathol 1994; 18: 126-135.
32. Busam K J, Rosai J, Iversen K, Jungbluth A A. Xanthogranulomas with inconspicuous foam cells and giant cells mimicking malignant melanoma: a clinical, histologic, and immunohistochemical study of three cases. Am J Surg Pathol 2000; 24: 864-869.
33. Shapiro P E, Silvers D N, Treiber R K, Cooper P H, True L D, Lattes R. Juvenile xanthogranulomas with inconspicuous or absent foam cells and giant cells. J Am Acad Dermatol 1991; 24: 1005-1009.
34. Busam K J, Granter S R, Iversen K, Jungbluth A A. Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic naevi. Am J Dermatopathol 2000; 22: 237-241.
35. Kraus M D, Haley J C, Ruiz R, Essary L, Moran C A, Fletcher C D. "Juvenile" xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol 2001; 23: 104-111.
36. Tomaszewski M M, Lupton G P. Unusual expression of S-100 protein in histiocytic neoplasms. J Cutan Pathol 1998; 25: 129-135.
37. Sakamoto A, Oda Y, Itakura E et al. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma. Mod Pathol 2001; 14: 581-588.
38. Fretzin D F, Helwig E B. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973; 31: 1541-1552.
39. Helwig E B, May D. Atypical fibroxanthoma of the skin with metastasis. Cancer 1986; 57: 368-376.
40. Sakamoto A, Oda Y, Itakura, E et al. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma. Hum Pathol 2001; 32: 1225-1231.
41. Monteagudo C, Calduch L, Navarro S, Joan-Figueroa A, Llombart-Bosch A. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol 2002; 117: 126-131.
42. Longacre T A, Smoller B R, Rouse R V. Atypical fibroxanthoma. Multiple immunohistologic profiles. Am J Surg Pathol 1993; 17: 1199-1209.
43. Diaz-Cascajo C, Weyers W, Borghi S. Pigmented atypical fibroxanthoma: a tumour that may be easily mistaken for malignant melanoma. Am J Dermatopathol 2003; 25: 1-5.
44. Evans H L, Smith J L. Spindle cell squamous carcinomas and sarcoma-like tumours of the skin: a comparative study of 38 cases. Cancer 1980; 45: 2687-2697.
45. Argenyi Z B. Spindle cell neoplasms of the skin: a comprehensive diagnostic approach. Semin Dermatol 1989; 8: 283-297.
46. Sigel J E, Skacel M, Bergfeld W F, House N S, Rabkin M S, Goldblum J R. The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2001; 28: 520-524.
47. Pool S E, Manieei F, Clark W H, Jr., Harrist T J. Dermal squamo-melanocytic tumour: a unique biphenotypic neoplasm of uncertain biological potential. Hum Pathol 1999; 30: 525-529.
48. Kamino H, Tam S T, Alvarez L. Malignant melanoma with pseudocarcinomatous hyperplasia-an entity that can simulate squamous cell carcinoma. A light-microscopic and immunohistochemical study of four cases. Am J Dermatopathol 1990; 12: 446-451.
49. Marrogi A J, Hunt S J, Cruz D J. Cutaneous epithelioid angiosarcoma. Am J Dermatopathol 1990; 12: 350-356.
50. Prescott R J, Baneriee S S, Eyden B P, Haboubi N Y. Cutaneous epithelioid angiosarcoma: a clinicopathological study of four cases. Histopathology 1994; 25: 421-429.
51. Fields J P, Helwig E B. Leiomyosarcoma of the skin and subcutaneous tissue. Cancer 1981; 47: 156-169.
52. Kaddu S, Beham A, Cerroni L et al. Cutaneous leiomyosarcoma. Am J Surg Pathol 1997; 21: 979-987.
53. Swanson P E, Stanley M W, Scheithauer B W, Wick M R. Primary cutaneous leiomyosarcoma. A histological and immunohistochemical study of 9 cases, with ultrastructural correlation. J Cutan Pathol 1988; 15: 129-141.
54. Anstey A, McKee P, Jones E W. Desmoplastic malignant melanoma: a clinicopathological study of 25 cases. Br J Dermatol 1993; 129: 359-371.
55. Egbert B, Kempson R, Sagebiel R. Desmoplastic malignant melanoma. A clinicohistopathologic study of 25 cases. Cancer 1988; 62: 2033-2041.
56. Jain S, Allen P W. Desmoplastic malignant melanoma and its variants. A study of 45 cases. Am J Surg Pathol 1989; 13: 358-373.
57. Robson A, Allen P, Hollowood K. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma. Histopathology 2001; 38: 135-140.
58. Kaneishi N K, Cockerell C J. Histologic differentiation of desmoplastic melanoma from cicatrices. Am J Dermatopathol 1998; 20: 128-134.
59. Chorny J A, Barr R J. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma. Am J Dermatopathol 2002; 24: 309-312.
60. Longacre T A, Egbert B M, Rouse R V. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1996; 20: 1489-1500.